InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the full record of transactions filed by Borgeson Blake, Director. Director active across 1 companies, notably Recursion Pharmaceuticals, INC.. Aggregated, 14 filings have been recorded. Total volume traded: €434k. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations14 total
018,145 shares0
Class A Common Stock
SEC:0001209191-22-037642:0·
01,300 shares0
Class A Common Stock
SEC:0001209191-22-023320:0·
0555 shares0
Class A Common Stock
SEC:0001209191-22-002048·
0555 shares0
Class A Common Stock
SEC:0001209191-22-002048:0·
€160,0349,625 shares@ €16.626973.7% of flow
Class A Common Stock
SEC:0001209191-21-071103·
€160,0349,625 shares@ €16.62690.0074% mcap36.9% of flow
Class A Common Stock
SEC:0001209191-21-071103:0·
€26,2891,500 shares@ €17.52612.1% of flow
Class A Common Stock
SEC:0001209191-21-068920·
€26,2891,500 shares@ €17.5260.0012% mcap6.1% of flow
Class A Common Stock
SEC:0001209191-21-068920:0·
€30,7491,900 shares@ €16.183614.2% of flow
Class A Common Stock
SEC:0001209191-21-066254·
€30,7491,900 shares@ €16.18360.0014% mcap7.1% of flow
Class A Common Stock
SEC:0001209191-21-066254:0·
0457 shares0
Class A Common Stock
SEC:0001209191-21-059739·
0457 shares0
Class A Common Stock
SEC:0001209191-21-059739:0·
0278 shares0
Class A Common Stock
SEC:0001209191-21-045550·
0278 shares0
Class A Common Stock
SEC:0001209191-21-045550:0·
14 of 14 declarations
About Borgeson Blake
Blake Borgeson serves as a Board Member at Recursion Pharmaceuticals, Inc. He is involved in the governance of the company, bringing his expertise in the pharmaceutical sector. Recursion Pharmaceuticals focuses on using artificial intelligence to discover new drugs. Mr. Borgeson's experience enables him to effectively contribute to the strategic discussions of the board.
